Delivery Order SPE2DB22D9133-SPE2DB23FYY21
- Not listed
- The Defense Logistics Agency, a combat support agency within the Department of Defense, awarded a delivery order valued at four thousand five hundred seventy-three dollars and seventy-two cents ($4,573.72) to DMS Pharmaceutical Group Inc. The firm fixed price order is for VELCADE 3.5 MG VIALS to be delivered to a location in Park Ridge, Illinois between September 11, 2023 and October 2, 2023. No set aside designation or subcontractors are indicated. The Defense Logistics Agency manages the...
- The Defense Logistics Agency, a combat logistics support agency within the Department of Defense, awarded a firm fixed price delivery order valued at eleven thousand four hundred thirty-four dollars and thirty cents ($11,434.30) to DMS Pharmaceutical Group Incorporated. The order is for four hundred fifty-six thousand two hundred thirty-five (456,235) vials of the pharmaceutical Velcade at three and a half (3.5) milligrams per vial. Performance will take place at DMS Pharmaceutical's facility...
- The U.S. Defense Logistics Agency awarded a firm fixed-price delivery order contract valued at $11,434.30 to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois. The contract is for the supply of 4559578220 VELCADE 3.5 MG VIALS, with a completion date of January 26, 2023. DMS Pharmaceutical Group Inc. holds a larger indefinite delivery contract (IDC) with the Defense Logistics Agency under the SPE2DB program, valued at up to...
- The Defense Logistics Agency, a combat logistics support agency within the Department of Defense, awarded a firm fixed price delivery order valued at thirty-four thousand three hundred two dollars and ninety cents ($34,302.90) to DMS Pharmaceutical Group Incorporated. DMS will provide four hundred fifty-six thousand two hundred thirty-four thousand eighty-seven (4562345087) vials of the cancer drug Velcade (bortezomib) for injection to a military treatment facility located in Park Ridge,...
- The Defense Logistics Agency (DLA), an agency of the U.S. Department of Defense, awarded a delivery order valued at approximately $2,287 to DMS Pharmaceutical Group Inc. for VELCADE 3.5 MG VIALS. The firm fixed price order is being carried out under an unspecified existing contract vehicle and calls for DMS Pharmaceutical to deliver the specified pharmaceutical product to a location in Park Ridge, Illinois. Performance is required between August 4 and August 25, 2023. As the DLA supports...
- The Defense Logistics Agency, a combat logistics support agency within the Department of Defense, awarded a $2,286.86 firm fixed price delivery order to DMS Pharmaceutical Group Inc. for 4562330077 VELCADE 3.5 MG VIALS. The place of performance is Park Ridge, Illinois. The period of performance is from September 15, 2023 through October 6, 2023. No subcontractors or set aside designations were identified. This delivery order was likely placed against DLA's Pharmaceutical Prime Vendor contract to...
- The Defense Logistics Agency (DLA) awarded a firm fixed-price delivery order contract worth up to $23,314.40 to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois. The contract, which has a period of performance through June 24, 2024, is for the supply of VELCADE 3.5 MG VIALS to support the recurring medical supply needs of military health facilities worldwide. This delivery order is part of a larger indefinite delivery contract...
- This is a delivery order awarded by the Defense Logistics Agency (DLA) to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois. The order is part of a larger single-award indefinite delivery contract (IDC) with the DLA worth up to $499,999,999, which runs through December 31, 2025. The current delivery order is for $11,657.20 and is for the supply of 3.5 mg vials of the drug VELCADE. This order is placed under a firm fixed-price...
- This is a $23,314.40 firm fixed-price delivery order awarded by the Defense Logistics Agency (DLA) to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois. The contract is for the delivery of VELCADE 3.5 MG VIALS and has a completion date of June 4, 2024. DMS Pharmaceutical Group holds a significant $499,999,999 indefinite delivery contract (IDC) with the DLA under the SPE2DB program to provide a comprehensive range of pharmaceutical...
- This federal contract award was made by the Defense Logistics Agency (DLA), a defense agency within the U.S. Department of Defense, to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois. The contract, a firm fixed-price delivery order valued at $23,314.40, is for the supply of 4566144024 - VELCADE 3.5 MG VIALS. The delivery order is part of a larger indefinite delivery contract (IDC) valued at up to $499,999,999 that DMS...
- SPE2DB22D9133Indefinite Delivery Contract
- SPE2DB22D9133-SPE2DB23FYY21Delivery Order
The Defense Logistics Agency awarded a firm fixed price delivery order valued at twenty-two thousand eight hundred sixty-eight dollars and sixty cents ($22,868.60) to DMS Pharmaceutical Group Inc. of Park Ridge, Illinois. Under the contract, DMS Pharmaceutical Group will provide four hundred fifty-six thousand two hundred thirty-three (456,233) units of 3.5 mg VELCADE vials to the Defense Logistics Agency in support of Department of Defense requirements. Performance will occur at the prime contractor's facility in Park Ridge, Illinois over a three-week period concluding on September 28, 2023. No subcontractors or set aside designations were identified. This order is likely placed against an existing pharmaceuticals supply vehicle to support the medical needs of service members.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $22.9k | 9/7/23 |